Bud Light’s Market Share Hit by Boycotts. This Beer Stock Is Gaining.
Yahoo Finance » Cannabis, Marijuana, 420 Stocks
by
1h ago
BofA Securities analyst Bryan Spillane raised his rating on the brewer's stock to Neutral from Underperform ..read more
Visit website
Bud Light Is Set to Lose a Big Chunk of Its Business Permanently
Yahoo Finance » Cannabis, Marijuana, 420 Stocks
by
1h ago
The damage Bud Light has done to its brand may be irreparable. Anheuser Busch In-Bev Bud Light's parent company, can expect a "permanent 15% haircut," to Bud Light sales, Bernstein analysts Nadine Sarwat and Trevor Stirling wrote in a note, according to Forbes. Despite that grim outlook for Bud Light, the firm is still bullish on Anheuser Busch's stock due to its current price to earnings ratio of 15, its lowest in over a decade ..read more
Visit website
Aurora Cannabis to Host Third Quarter and Fiscal Year 2023 Investor Conference Call and File Related Year End Information
Yahoo Finance » Cannabis, Marijuana, 420 Stocks
by
1h ago
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, announced today that it has scheduled a conference call to discuss the results for its third quarter and full fiscal year 2023 on Wednesday, June 14, 2023 at 8:15 a.m. Eastern Time | 6:15 a.m. Mountain Time. The Company will report its financial results for the third quarter and full fiscal year 2023 before the opening of markets that same day. As a reminder, Fiscal 2023 ..read more
Visit website
Should You Invest in AbbVie (ABBV)?
Yahoo Finance » Cannabis, Marijuana, 420 Stocks
by
1h ago
Harding Loevner, an asset management company, released its “Global Equity Strategy” first-quarter 2023 investor letter. A copy of the same can be downloaded here. In the first quarter, the strategy returned 6.25% net of fees compared to a 7.44% return for the MSCI All Country World Index and 7.88% for the MSCI World Index. Exposure to ..read more
Visit website
AbbVie Announces Reimbursement for VRAYLAR® (cariprazine) for the Treatment of Schizophrenia under the Non-Insured Health Benefits (NIHB) Program
Yahoo Finance » Cannabis, Marijuana, 420 Stocks
by
1h ago
AbbVie (NYSE: ABBV), today announced that VRAYLAR is now listed as a Limited Use product on the formulary of the Non-Insured Health Benefits (NIHB)1 program for the treatment of schizophrenia ..read more
Visit website
Vertex (VRTX) Stock Poised Well for Growth in 2023: Here's Why
Yahoo Finance » Cannabis, Marijuana, 420 Stocks
by
1h ago
Vertex Pharmaceuticals (VRTX) stock is likely to be driven by several catalysts this year. Multiple clinical milestones are likely to be achieved in 2023 and 2024, both in its CF and non-CF portfolio ..read more
Visit website
3 Top-Ranked Stocks with Bullish Catalysts
Yahoo Finance » Cannabis, Marijuana, 420 Stocks
by
1h ago
Analysts seem emboldened by JPMs resolute actions during the banking crisis and have boosted expectations accordingly ..read more
Visit website
Bud Light volume improves slightly, but sales still down
Yahoo Finance » Cannabis, Marijuana, 420 Stocks
by
1h ago
Bud Light volume improved slightly last week, but sales are still down as the AB InBev brand continues to see fallout from its partnership with transgender influencer Dylan Mulvaney ..read more
Visit website

Follow Yahoo Finance » Cannabis, Marijuana, 420 Stocks on Feedspot

Continue with Google
Continue with Apple
OR